Consensus Caplin Point Laboratories Limited NSE India S.E.

Equities

CAPLIPOINT

INE475E01026

Market Closed - NSE India S.E. Other stock markets 12:43:52 24/05/2024 BST			5-day change	1st Jan Change
1,303 ^INR	-0.44%		-2.83%	-3.89%

05-24	Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution	MT
05-16	Caplin Point Laboratories to Seek Acquisitions	CI

Evolution of the average Target Price on Caplin Point Laboratories Limited

Price target over the last 5 years

History of analyst recommendation changes

f090b2e6fbb1d0edbbc8c0.FQKrZE920TtWJQmy1wVXQc9NM2z6e7qA0LmlKI6f2Ic.WWHiKRYugAk5R0aDtlUIDIg6ZCS-FdLm5PzxYc3arbJ5TJozIROjaTUXWA~2374c173f4ca5c638f8a82f41f1bd5be

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,302 INR

Average target price

1,579 INR

Spread / Average Target

+21.27%

High Price Target

1,660 INR

Spread / Highest target

+27.46%

Low Price Target

1,535 INR

Spread / Lowest Target

+17.86%

Consensus detail

Consensus revision (last 18 months)

Ratings for Caplin Point Laboratories Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar